REGENXBIO
RGNX
$16.06
Share price
0.12%
Change (1 day)
-15.12%
Change (1 year)
Categories
Operating Margin for REGENXBIO (RGNX)
Operating Margin as of April 2024 (TTM): -228.41%
According to REGENXBIO's latest financial reports and stock price the company's current Operating Margin is -228.41%. At the end of 2021 the company had an Operating Margin of 30.03%.
Operating Margin history for REGENXBIO from 2015 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | 30.03% | -143.79% |
| 2020 | -68.59% | -75.21% |
| 2019 | -276.70% | -680.69% |
| 2018 | 47.65% | -106.77% |
| 2017 | -704.02% | -49.04% |
| 2016 | -1,381.61% | 359.59% |
| 2015 | -300.62% | 359.6% |
| 2014 | -65.41% | -26.09% |
| 2013 | -88.50% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.